Genetic Markers Enhance Coronary Risk Prediction in Men: The MORGAM Prospective Cohorts
Open Access
- 25 July 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (7), e40922
- https://doi.org/10.1371/journal.pone.0040922
Abstract
More accurate coronary heart disease (CHD) prediction, specifically in middle-aged men, is needed to reduce the burden of disease more effectively. We hypothesised that a multilocus genetic risk score could refine CHD prediction beyond classic risk scores and obtain more precise risk estimates using a prospective cohort design. Using data from nine prospective European cohorts, including 26,221 men, we selected in a case-cohort setting 4,818 healthy men at baseline, and used Cox proportional hazards models to examine associations between CHD and risk scores based on genetic variants representing 13 genomic regions. Over follow-up (range: 5–18 years), 1,736 incident CHD events occurred. Genetic risk scores were validated in men with at least 10 years of follow-up (632 cases, 1361 non-cases). Genetic risk score 1 (GRS1) combined 11 SNPs and two haplotypes, with effect estimates from previous genome-wide association studies. GRS2 combined 11 SNPs plus 4 SNPs from the haplotypes with coefficients estimated from these prospective cohorts using 10-fold cross-validation. Scores were added to a model adjusted for classic risk factors comprising the Framingham risk score and 10-year risks were derived. Both scores improved net reclassification (NRI) over the Framingham score (7.5%, p = 0.017 for GRS1, 6.5%, p = 0.044 for GRS2) but GRS2 also improved discrimination (c-index improvement 1.11%, p = 0.048). Subgroup analysis on men aged 50–59 (436 cases, 603 non-cases) improved net reclassification for GRS1 (13.8%) and GRS2 (12.5%). Net reclassification improvement remained significant for both scores when family history of CHD was added to the baseline model for this male subgroup improving prediction of early onset CHD events. Genetic risk scores add precision to risk estimates for CHD and improve prediction beyond classic risk factors, particularly for middle aged men.This publication has 31 references indexed in Scilit:
- Genetic Susceptibility to Coronary Heart Disease in Type 2 Diabetes: 3 Independent StudiesJournal of the American College of Cardiology, 2011
- Large-scale association analysis identifies 13 new susceptibility loci for coronary artery diseaseNature Genetics, 2011
- Effect of Direct-to-Consumer Genomewide Profiling to Assess Disease RiskThe New England Journal of Medicine, 2011
- Performance of reclassification statistics in comparing risk prediction modelsBiometrical Journal, 2011
- A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analysesThe Lancet, 2010
- Association Between a Literature-Based Genetic Risk Score and Cardiovascular Events in WomenJAMA, 2010
- Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variantsNature Genetics, 2009
- New susceptibility locus for coronary artery disease on chromosome 3q22.3Nature Genetics, 2009
- The impact of newly identified loci on coronary heart disease, stroke and total mortality in the MORGAM prospective cohortsGenetic Epidemiology, 2008
- A Fast and Flexible Statistical Model for Large-Scale Population Genotype Data: Applications to Inferring Missing Genotypes and Haplotypic PhaseAmerican Journal of Human Genetics, 2006